Abstract
Novel 1,4-dihydropyridine derivatives bearing 3-[4-(substituted amino)phenylalkyl]ester side chains were prepared and tested for their antihypertensive activity in spontaneously hypertensive rats. Most compounds showed a more potent antihypertensive effect and a longer duration of action than nicardipine. The derivatives with a benzhydrylpiperazinyl and a benzhydrylpiperidinyl group were distinctive. 2-[4-(4-Benzhydryl-l-piperazinyl)phenyl]ethyl methyl 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-pyridinedicarboxylate (4e), its 4-(4-cyano-2-pyridyl) analogue (4f), its 3-[4-(4-benzhydryl-l-piperazinyl)phenyl]propyl ester analogue (4h), its 2-[4-(4-benzhydryl-l-piperidinyl)phenyl]ethyl ester analogue (4j), and its 2-[4-(l-benzhydryl-4-piperidinyl)phenyl]ethyl ester analogue (4k) were selected as candidates for further pharmacological investigations. © 1991, The Pharmaceutical Society of Japan. All rights reserved.
Author supplied keywords
Cite
CITATION STYLE
Ashimori, A., Ono, T., Inoue, Y., Morimoto, S., Eda, M., Uchida, T., … Yokoyama, K. (1991). Novel 1,4-Dihydropyridine Calcium Antagonists: II: Synthesis and Antihypertensive Activity of 3-[4-(Substituted Amino)phenylalkyl]ester Derivatives. Chemical and Pharmaceutical Bulletin, 39(1), 91–99. https://doi.org/10.1248/cpb.39.91
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.